HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation.

AbstractAIMS:
We aim to determine the significant effect of TPEN, a Zn(2+) chelator, in mediating the pathophysiological cascade in neuron death/apoptosis induced by hypoxia/ischemia.
METHODS:
We conducted both in vivo and in vitro experiments in this study. PC12 cells were used to establish hypoxia/ischemia model by applying oxygen-glucose deprivation (OGD). SHR-SP rats were used to establish an acute ischemic model by electrocoagulating middle cerebral artery occlusion. The effect of TPEN on neuron death/apoptosis was evaluated. In addition, the relative biomarks of excitotoxicity, oxidative stress, and inflammation reactions in hypoxia/ischemia PC12 cell model as well as in SHR-SP rat hypoxia/ischemia model were also assessed.
RESULTS:
TPEN significantly attenuates the neurological deficit, reduced the cerebral infarction area and the ratio of apoptotic neurons, and increased the expression of GluR2 in the rat hypoxia/ischemia brain. TPEN also increased blood SOD activity, decreased blood NOS activity and blood MDA and IL-6 contents in rats under hypoxia/ischemia. In addition, TPEN significantly inhibited the death and apoptosis of cells and attenuated the alteration of GluR2 and NR2 expression caused by OGD or OGD plus high Zn(2+) treatments.
CONCLUSIONS:
Zn(2+) is involved in neural cell apoptosis and/or death caused by hypoxia/ischemia via mediating excitotoxicity, oxidative stress, and inflammation.
AuthorsWei-Ming Wang, Zhao Liu, Ai-Jun Liu, Yu-Xiang Wang, Hong-Gang Wang, Di An, Bin Heng, Lai-Hua Xie, Jun-Li Duan, Yan-Qiang Liu
JournalCNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 21 Issue 9 Pg. 708-17 (Sep 2015) ISSN: 1755-5949 [Electronic] England
PMID26190227 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 John Wiley & Sons Ltd.
Chemical References
  • Chelating Agents
  • Ethylenediamines
  • Neuroprotective Agents
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • Glucose
  • Zinc
  • glutamate receptor ionotropic, AMPA 2
  • N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
Topics
  • Animals
  • Apoptosis (drug effects, physiology)
  • Brain (drug effects, pathology, physiopathology)
  • Brain Ischemia (drug therapy, pathology, physiopathology)
  • Cell Hypoxia (drug effects, physiology)
  • Chelating Agents (pharmacology)
  • Disease Models, Animal
  • Ethylenediamines (pharmacology)
  • Female
  • Glucose (deficiency)
  • Infarction, Middle Cerebral Artery
  • Ischemia (drug therapy, pathology, physiopathology)
  • Neuroimmunomodulation (drug effects, physiology)
  • Neurons (drug effects, pathology, physiology)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Stress (drug effects, physiology)
  • PC12 Cells
  • Rats
  • Rats, Inbred SHR
  • Receptors, AMPA (metabolism)
  • Receptors, N-Methyl-D-Aspartate (metabolism)
  • Zinc (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: